Expanded Access for ACE-011

Celgene

Status

Conditions: Myelodysplastic Syndrome

Treatments: Drug: ACE-011

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT03724227

ACE-011

Details and patient eligibility

About

This is an expanded access program (EAP) for eligible participants designed to provide access to ACE-011.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria